| Miss Jacqueline Lopez, MA, CCC-SLP | |
|
4220 80th St Ne, Marysville, WA 98270-3423 | |
| (360) 657-6415 | |
| Not Available |
| Full Name | Miss Jacqueline Lopez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4220 80th St Ne, Marysville, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639506637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00003404 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Jacqueline Lopez, MA, CCC-SLP 8825 34th Ave Ne Ste L, Quil Ceda Village, WA 98271-8085 Ph: (360) 965-0751 | Miss Jacqueline Lopez, MA, CCC-SLP 4220 80th St Ne, Marysville, WA 98270-3423 Ph: (360) 657-6415 |
News Archive
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Adaptimmune today announced that it has been awarded a grant of £2.1 million from the Biomedical Catalyst Fund, managed by the UK's innovation agency the Technology Strategy Board and the Medical Research Council. The prestigious award will expedite the development of Adaptimmune's second engineered T cell therapy programme into the clinic in triple negative breast cancer.
USC researchers and collaborators report a breakthrough to prevent damage to the jaw, a side effect suffered by some people undergoing treatment for cancer or osteoporosis.
Canada today announced a CDN$10 million extension of core funding through 2025 for the UN University Institute for Water, Environment and Health, a research organization at the forefront of pressing global water challenges.
NeoPharm, Inc., a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has completed its merger with Insys Therapeutics, Inc., a Phoenix, AZ based pharmaceutical company.
› Verified 4 days ago
Deborah Bradley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-0896 | |
Dr. Paul Morphy, PHD CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6325 91st St Ne, Marysville, WA 98270 Phone: 360-965-1966 | |
Graham Lucas Chattin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-965-0000 | |
Miss Barbara Andrea Herrera Rojas, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14500 51st Ave Ne, Marysville, WA 98271 Phone: 360-965-8687 | |
Marysville School District Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th Street Ne, Marysville School District, Marysville, WA 98270 Phone: 360-653-7058 Fax: 360-657-6824 | |
Maryann Walters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4220 80th St Ne, Marysville, WA 98270 Phone: 360-653-7058 | |
Caitlin Schauer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4407 116th St Ne, Marysville, WA 98271 Phone: 360-965-1649 |